Skip to main content
. 2023 Jun 30;14:1177403. doi: 10.3389/fimmu.2023.1177403

Figure 4.

Figure 4

Correlation of LMR with relapse-free survival in all subtypes of ovarian cancer. RFS in patients with differential LMR level in patients with age ≤ 55 years (A), patients with age>55 years (B), patients with non-menopause (C), patients with menopause (D), patients with FIGO stage I (E), patients with FIGO stage II (F), patients with FIGO stage III (G), patients with FIGO stage IV (H), patients without family history of cancer (I), patients with family history of cancer (J), patients with residual disease ≤ 1cm (K), patients with residual disease >1cm (L), patients with histology serous (M), patients with histology other (N), patients without lymph node metastasis (O), patients with lymph node metastasis (P), patients with grade well (Q), patients with grade moderate (R), patients with grade poorly (S).